UB Paderborn / Katalog / Suche / in CDI

Status of vaccine research and development of vaccines for malaria

Vaccine, 2016-06, Vol.34 (26), p.2915-2920

Birkett, Ashley J.

2016

Link zum Volltext

Verfügbarkeit prüfen

Building an effective malaria vaccine pipeline to address global needs

Vaccine, 2015-12, Vol.33 (52), p.7538-7543

Birkett, Ashley J

2015

Link zum Volltext

Verfügbarkeit prüfen

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities

Vaccine, 2013-04, Vol.31, p.B233-B243

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles Expressing Plasmodium falciparum Circumsporozoite Epitopes

Infection and Immunity, 2004-11, Vol.72 (11), p.6519-6527

2004

Link zum Volltext

Verfügbarkeit prüfen

Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challenge

Infection and Immunity, 2007-12, Vol.75 (12), p.5819-5826

2007

Link zum Volltext

Verfügbarkeit prüfen

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

The Journal of infectious diseases, 2016-09, Vol.214 (5), p.762-771

2016

Link zum Volltext

Verfügbarkeit prüfen

Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward

Vaccine, 2014-09, Vol.32 (43), p.5531-5539

2014

Link zum Volltext

Verfügbarkeit prüfen

Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission

Biochemistry (Easton), 2018-02, Vol.57 (5), p.516-519

2018

Link zum Volltext

Verfügbarkeit prüfen

An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria

Science translational medicine, 2020-05, Vol.12 (544)

2020

Link zum Volltext

Verfügbarkeit prüfen

Status of vaccine research and development of vaccines for malaria prepared for WHO PD-VAC

Vaccine, 2016

Birkett, Ashley J

2016

Link zum Volltext

Verfügbarkeit prüfen

Aligning new interventions with developing country health systems: Target product profiles, presentation, and clinical trial design

Global public health, 2012-10, Vol.7 (9), p.931-945

2012

Link zum Volltext

Verfügbarkeit prüfen

Antibodies against Thrombospondin-Related Anonymous Protein Do Not Inhibit Plasmodium Sporozoite Infectivity In Vivo

Infection and Immunity, 2000-06, Vol.68 (6), p.3667-3673

2000

Link zum Volltext

Verfügbarkeit prüfen

PATH Malaria Vaccine Initiative (MVI): Perspectives on the status of malaria vaccine development

Human vaccines, 2010-01, Vol.6 (1), p.139-145

Birkett, Ashley J.

2010

Link zum Volltext

Verfügbarkeit prüfen

Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques

Vaccine, 2005-09, Vol.23 (41), p.4935-4943

2005

Link zum Volltext

Verfügbarkeit prüfen

PATH Malaria Vaccine Initiative (MVI): Perspectives on the status of malaria vaccine development

Human vaccines & immunotherapeutics, 2010-01, Vol.6 (1), p.139-145

Ashley J. Birkett

2010

Link zum Volltext

Verfügbarkeit prüfen

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities: Decade of Vaccines

Vaccine, 2013, Vol.31

2013

Link zum Volltext

Verfügbarkeit prüfen

Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challeng

Infection and immunity, 2007, Vol.75 (12), p.5819-5826

2007

Link zum Volltext

Verfügbarkeit prüfen

Cloning, expression, purification, and characterization of the major core protein (p26) from equine infectious anemia virus

Biochimica et biophysica acta, 1997-04, Vol.1339 (1), p.62-72

1997

Link zum Volltext

Verfügbarkeit prüfen

Determination of enzyme specificity in a complex mixture of peptide substrates by N-terminal sequence analysis

Analytical biochemistry, 1991-07, Vol.196 (1), p.137-143

1991

Link zum Volltext

Verfügbarkeit prüfen

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy

PLoS neglected tropical diseases, 2016-02, Vol.10 (2), p.e0004423-e0004423

2016

Link zum Volltext

Verfügbarkeit prüfen

The Importance of Exercising Caution When Comparing Results from Malaria Vaccines Administered on the EPI Schedule and on a Seasonal Schedule / Reply

The American journal of tropical medicine and hygiene, 2022-12, Vol.107 (6), p.1356

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial

Infection and Immunity, 2005-06, Vol.73 (6), p.3587-3597

2005

Link zum Volltext

Verfügbarkeit prüfen

A slot blot immunoassay for quantitative detection of Plasmodium falciparum circumsporozoite protein in mosquito midgut oocyst

PloS one, 2014-12, Vol.9 (12), p.e115807-e115807

2014

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Status of vaccine research and development of vaccines for malaria

Building an effective malaria vaccine pipeline to address global needs

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities

Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers

Phase I Testing of a Malaria Vaccine Composed of Hepatitis B Virus Core Particles Expressing Plasmodium falciparum Circumsporozoite Epitopes

Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challenge

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study

Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward

Malaria Derived Glycosylphosphatidylinositol Anchor Enhances Anti-Pfs25 Functional Antibodies That Block Malaria Transmission

Safety, tolerability, and Plasmodium falciparum transmission-reducing activity of monoclonal antibody TB31F: a single-centre, open-label, first-in-human, dose-escalation, phase 1 trial in healthy malaria-naive adults

An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria

Status of vaccine research and development of vaccines for malaria prepared for WHO PD-VAC

Aligning new interventions with developing country health systems: Target product profiles, presentation, and clinical trial design

Antibodies against Thrombospondin-Related Anonymous Protein Do Not Inhibit Plasmodium Sporozoite Infectivity In Vivo

PATH Malaria Vaccine Initiative (MVI): Perspectives on the status of malaria vaccine development

Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques

PATH Malaria Vaccine Initiative (MVI): Perspectives on the status of malaria vaccine development

Malaria vaccine R&D in the Decade of Vaccines: Breakthroughs, challenges and opportunities: Decade of Vaccines

Combination of Protein and Viral Vaccines Induces Potent Cellular and Humoral Immune Responses and Enhanced Protection from Murine Malaria Challeng

Cloning, expression, purification, and characterization of the major core protein (p26) from equine infectious anemia virus

Determination of enzyme specificity in a complex mixture of peptide substrates by N-terminal sequence analysis

Phase 1/2a Trial of Plasmodium vivax Malaria Vaccine Candidate VMP001/AS01B in Malaria-Naive Adults: Safety, Immunogenicity, and Efficacy

The Importance of Exercising Caution When Comparing Results from Malaria Vaccines Administered on the EPI Schedule and on a Seasonal Schedule / Reply

Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial

A slot blot immunoassay for quantitative detection of Plasmodium falciparum circumsporozoite protein in mosquito midgut oocyst

Suchergebnisse filtern